CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,763 | +230.8% | 35,646 | +64.4% | 0.00% | – |
Q4 2022 | $4,765 | -68.2% | 21,688 | -3.5% | 0.00% | – |
Q2 2022 | $15,000 | -37.5% | 22,472 | -23.3% | 0.00% | – |
Q1 2022 | $24,000 | -38.5% | 29,315 | -13.0% | 0.00% | – |
Q4 2021 | $39,000 | -86.7% | 33,711 | -71.2% | 0.00% | – |
Q3 2021 | $293,000 | +261.7% | 116,997 | +323.1% | 0.00% | – |
Q2 2021 | $81,000 | +107.7% | 27,651 | +148.6% | 0.00% | – |
Q1 2021 | $39,000 | -91.5% | 11,124 | -88.5% | 0.00% | – |
Q4 2020 | $459,000 | -50.8% | 96,611 | -49.6% | 0.00% | – |
Q3 2020 | $932,000 | +348.1% | 191,728 | +199.2% | 0.00% | – |
Q2 2020 | $208,000 | +123.7% | 64,073 | +254.4% | 0.00% | – |
Q1 2020 | $93,000 | – | 18,079 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,721,299 | $10,672,000 | 1.91% |
ARS Investment Partners, LLC | 785,343 | $4,869,000 | 0.63% |
PERKINS CAPITAL MANAGEMENT INC | 35,500 | $220,000 | 0.23% |
Benchmark Capital Advisors | 32,900 | $204,000 | 0.16% |
FNY Managed Accounts LLC | 2,784 | $17,000 | 0.02% |
THOMPSON DAVIS & CO., INC. | 1,500 | $9,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,100 | $497,000 | 0.01% |
WELLINGTON MANAGEMENT GROUP LLP | 918,535 | $5,695,000 | 0.00% |
ROYCE & ASSOCIATES LP | 21,900 | $136,000 | 0.00% |
Phocas Financial Corp. | 20,000 | $0 | 0.00% |